ACELYRIN (SLRN) - News Mentions

Sign up to add (SLRN) to your portfolio and access more historical data.

00%
Est. daily news mentions.

Sign up to access historical data

Sign up

Similar companies

Company News Mentions
Amgen
Amgen
AMGN		 1 0%
Gilead Sciences
Gilead Sciences
GILD		 1 50%
Catalyst Pharmaceuticals
Catalyst Pharmaceuticals
CPRX		 0 0%
Inovio Pharmaceuticals
Inovio Pharmaceuticals
INO		 0 0%
Anavex Life Sciences
Anavex Life Sciences
AVXL		 0 100%
Acelyrin, Inc. (NASDAQ:SLRN) Receives $11.50 Consensus Price Target from Brokerages
November 27
Acelyrin (NASDAQ:SLRN) Price Target Raised to $8.00 at HC Wainwright
November 18
Acelyrin Inc (SLRN) Q3 2024 Earnings Call Highlights: Strategic Pipeline Refocus and Financial ...
November 13
Acelyrin, Inc. (SLRN) Q3 2024 Earnings Call Transcript
November 13
ACELYRIN, INC. Reports Third Quarter 2024 Financial Results and Recent Highlights
November 13
ACELYRIN : Reports Third Quarter 2024 Financial Results and Recent Highlights Form 8 K
November 13
ACELYRIN, INC. to Report Third Quarter 2024 Financial Results and Corporate Update on November 13, 2024
November 6
Brokerages Set Acelyrin, Inc. (NASDAQ:SLRN) Price Target at $11.17
October 30
Acelyrin, Inc. (NASDAQ:SLRN) Given Consensus Rating of "Moderate Buy" by Analysts
October 27
Acelyrin, Inc. (NASDAQ:SLRN) Short Interest Down 19.2% in October
October 27
The Manufacturers Life Insurance Company Acquires 4,163 Shares of Acelyrin, Inc. (NASDAQ:SLRN)
October 20
Acelyrin (NASDAQ:SLRN) Stock Price Down 6.9% - Here's What Happened
October 18
Wells Fargo & Company Boosts Acelyrin (NASDAQ:SLRN) Price Target to $15.00
October 16
ACELYRIN, INC. Forms Scientific and Patient Advisory Board Featuring Leading Voices in Thyroid Eye Disease
October 15
Promising Outlook for ACELYRIN’s Izokibep in Uveitis Treatment Drives Buy Recommendation
October 15
Acelyrin (NASDAQ:SLRN) Stock Price Down 2.4% - What's Next?
October 11

How often is ACELYRIN mentioned in the news?

ACELYRIN was mentioned an estimated 0 times in online prominent news articles yesterday.

Analyzing News Mentions, how is ACELYRIN performing compared to its industry peers?

ACELYRIN underperforms its industry peers when it comes to News Mentions, ranking dead last.

Has there been an increase or decrease in news mentions of ACELYRIN in the last month?

There has been no significant change in the number of news mentions for ACELYRIN's compared to the last month.

Why is it important to track news mentions for ACELYRIN?

By monitoring mentions in the news for ACELYRIN, investors stay up to date on impactful events for the company, its industry and its competitors. Positive news might affect price in a positive way and negative news might affect price in a negative way. By tracking mentions over time, investors can also identify patterns, explore popularity and make informed decisions based on the evolving perception of ACELYRIN, ultimately improving their investment strategies.

Sign up and get more insights on ACELYRIN.

The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.
About Us

AltIndex revolutionizes investing with advanced alternative data analytics, smart insights, and stock alerts, presented in an easy-to-use dashboard powered by comprehensive company data from across the internet.



App download

Legal Disclaimer
The information provided by AltIndex is solely for informational purposes and not a substitute for professional financial advice. Investing in financial markets carries inherent risks, and past performance doesn't guarantee future results. It's crucial to do your research, consult with financial experts, and align your financial objectives and risk tolerance before investing. AltIndex creators and operators are not liable for any financial losses incurred from using this information. Users should exercise caution, seek professional advice, and be prepared for the risks involved in trading and investing in financial assets, only investing what they can afford to lose. The information in this application, derived from publicly available data, is believed to be reliable but may not always be accurate or current. Users should verify information independently and not solely rely on this application for financial decisions. By using AltIndex, you acknowledge that it doesn't offer financial advice and agree to consult a qualified financial advisor before making investment decisions.

© 2024 AltIndex. All rights reserved.

Top Stocks

Trending Stocks
Trending Stocks on WallStreetBets
Trending Stocks on Reddit
Top Stocks
Top Stock Performers Today
Bottom Stock Performers Today
Best Airlines Stocks
Best Bank Stocks
Best Semiconductor Stocks
Best Energy Stocks
Best Fintech Stocks
Best Robotics Stocks
Best Insurance Stocks

Our Data

Datasets
Stock alerts
AI Stock Picks
AI Stock Picks - Results
Fear & Greed Index
Meme Stocks
Threads Users
Stock Predictor
Stock Picking Reviews
Stock Trading Signals
House & Congress Trading
Earnings Calendar
Index

AltIndex

News
Pricing
Sign up
Log in
API
Journalist Access
Data Disclaimer
Contact